Tools for Practice Outils pour la pratique


MIGS Hospital Medicine Video Activity – 197526







CFPCLearn Logo

Reading Tools for Practice Article can earn you MainPro+ Credits

La lecture d'articles d'outils de pratique peut vous permettre de gagner des crédits MainPro+

Join Now S’inscrire maintenant

Already a CFPCLearn Member? Log in

Déjà abonné à CMFCApprendre? Ouvrir une session





dianne stackhouse February 15, 2022

informative

dianne stackhouse February 15, 2022

none

dianne stackhouse February 15, 2022

none

Yang Sheng April 10, 2022

Maybe tie lecture more to mortality rates or factors for COVID

Mohamed Goolam Hussain April 18, 2022

This sort of discussion would be very useful to medical students early in their training.

Victoria Chang January 5, 2023

Thank you.

Victoria Chang February 6, 2023

thank you

Victoria Chang February 7, 2023

Thank you.

Allen Wong April 2, 2023

n/a

John Mah September 20, 2023

thank you

Muthanna Kettana November 22, 2023

NA

Muthanna Kettana November 22, 2023

NA

Muthanna Kettana November 22, 2023

NA

Muthanna Kettana November 22, 2023

NA

Robert Ian Maxwell December 14, 2023

None

shamsuddin chaudhry March 11, 2024

Excellent

Fouad El-Ganga June 28, 2024

Thank you

darren bugbee October 5, 2024

None.

b keith comeau May 2, 2025

Thank you

Allan Kopyto May 27, 2025

nil

Allan Kopyto May 27, 2025

none

Allan Kopyto May 27, 2025

none

Allan Kopyto May 29, 2025

Nine


Latest Tools for Practice
Derniers outils pour la pratique

#414 A Tough Nut to Crack: Does oral immunotherapy improve outcomes in peanut allergy?

In children with peanut allergy, does oral immunotherapy increase peanut tolerance, and what are the adverse effects?
Read Lire 0.25 credits available Crédits disponibles

#413 Itchy Beginnings: Can we calm infant eczema?

In infants under 2, how effective and safe are topical treatments for eczema?
Read Lire 0.25 credits available Crédits disponibles

#412 PCSK9 Inhibitors: Cardiovascular prevention panacea or pricey pokes?

Are PCSK9 inhibitors (evolocumab, alirocumab) effective in preventing cardiovascular events?
Read Lire 0.25 credits available Crédits disponibles

This content is certified for MainPro+ Credits, log in to access

Ce contenu est certifié pour les crédits MainPro+, Ouvrir une session


Authors do not have any conflicts of interest to declare.

Les auteurs n’ont aucun conflit d’intérêts à déclarer.